Overview

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer: a randomized, double blind, placebo-controlled study.
Phase:
Phase 3
Details
Lead Sponsor:
Fadoi Foundation, Italy
Collaborator:
University Of Perugia
Treatments:
Rivaroxaban